Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00531687
Recruitment Status : Terminated (slow accrual)
First Posted : September 19, 2007
Last Update Posted : October 3, 2017
Information provided by (Responsible Party):
Gedske Daugaard, Rigshospitalet, Denmark

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : February 2012
  Actual Study Completion Date : October 2016